Last 12 months
Inside the activity.
0 purchase rows · 457 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 47 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 41 |
| Feb 2026 | 0 | 21 |
| Mar 2026 | 0 | 54 |
| Apr 2026 | 0 | 29 |
| May 2026 | 0 | 33 |
| Jun 2026 | 0 | 68 |
| Jul 2026 | 0 | 47 |
| Aug 2026 | 0 | 33 |
| Sep 2026 | 0 | 59 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2024 Filed Oct 4, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 729 | $126.27 | $92,051.05 |
DisclosureSEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 5 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 57,432 F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.78 to $126.5050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| October 01, 2024 Filed Oct 4, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 771 | $125.23 | $96,550.33 |
DisclosureSEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 4 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 58,161 F5 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.78 to $125.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| October 01, 2024 Filed Oct 4, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 427 | $126.42 | $53,981.60 |
DisclosureSEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,041 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.33 to $126.5050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2024 Filed Oct 4, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 1,397 | $125.83 | $175,785.21 |
DisclosureSEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,468 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.32 to $126.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2024 Filed Oct 4, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 876 | $124.82 | $109,346.17 |
DisclosureSEC source: 0001415889-24-024709 · form4-10032024_091001.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,865 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.27 to $125.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2024 Filed Sep 21, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 3,066 | $128.07 | $392,677.34 |
DisclosureSEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 6 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 2 Trust Disclosed balance after: 58,932 F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.8100 to $128.2650 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| September 18, 2024 Filed Sep 21, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 6,584 | $127.39 | $838,704.16 |
DisclosureSEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 5 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 2 Trust Disclosed balance after: 61,998 F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7800 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| September 18, 2024 Filed Sep 21, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 3,246 | $128.06 | $415,677.89 |
DisclosureSEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 4 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 58,932 F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.8400 to $128.3250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| September 18, 2024 Filed Sep 21, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 6,404 | $127.38 | $815,728.07 |
DisclosureSEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Indirect · By Caraluna 1 Trust Disclosed balance after: 62,178 F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities. Read SEC document |
| September 18, 2024 Filed Sep 21, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 778 | $128.06 | $99,628.35 |
DisclosureSEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,741 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.85 to $128.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2024 Filed Sep 21, 2024 01:35 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 1,922 | $127.38 | $244,821.67 |
DisclosureSEC source: 0001415889-24-023812 · form4-09202024_090901.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,519 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.7950 to $127.7400 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 19, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 500 | $130.93 | $65,466.00 |
DisclosureSEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 5 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 195,686 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.83 to $131.18 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 19, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 598 | $129.90 | $77,677.99 |
DisclosureSEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 4 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,186 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.6400 to $130.3450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 19, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 1,626 | $128.87 | $209,539.21 |
DisclosureSEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 3 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,784 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.46 to $129.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 19, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 1,258 | $127.83 | $160,806.87 |
DisclosureSEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,410 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.41 to $128.40 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 19, 2024 01:35 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 1,042 | $126.66 | $131,983.99 |
DisclosureSEC source: 0001415889-24-023669 · form4-09182024_090901.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 199,668 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.3500 to $126.8350 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 01:05 UTC |
Chapman Rowan EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,614 | $0.00 Strike: $94.14 | $0.00 |
DisclosureSEC source: 0001415889-24-023469 · form4-09162024_090901.xml · derivative · entry 3 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,614 shares Expires 2031-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 01:05 UTC |
Chapman Rowan EDirector
|
SaleCommon Stock | 2,614 | $127.68 | $333,755.52 |
DisclosureSEC source: 0001415889-24-023469 · form4-09162024_090901.xml · nonDerivative · entry 2 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,969 Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 01:05 UTC |
Chapman Rowan EDirector
|
Exercise / conversionCommon Stock | 2,614 | $94.14 | $246,081.96 |
DisclosureSEC source: 0001415889-24-023469 · form4-09162024_090901.xml · nonDerivative · entry 1 Chapman Rowan E · CIK 0001786240 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 17, 2024 01:40 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 577 | $120.00 | $69,240.00 |
DisclosureSEC source: 0001415889-24-021534 · form4-08162024_090804.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,710 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. Read SEC document |
| August 15, 2024 Filed Aug 17, 2024 01:40 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 5,006 | $118.79 | $594,655.23 |
DisclosureSEC source: 0001415889-24-021534 · form4-08162024_090804.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,287 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.51 to $119.3050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2024 Filed Aug 17, 2024 01:40 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 12,000 | $121.01 | $1,452,124.80 |
DisclosureSEC source: 0001415889-24-021533 · form4-08162024_090801.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,441 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 01:05 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 3,956 | $116.67 | $461,546.52 |
DisclosureSEC source: 0001415889-24-021326 · form4-08142024_090801.xml · nonDerivative · entry 2 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 114,606 F3 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on August 12, 2022. Read SEC document |
| August 12, 2024 Filed Aug 15, 2024 01:05 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
GrantCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-021326 · form4-08142024_090801.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,562 F1 · shares: On August 12, 2022, the Reporting Person was granted performance-based Restricted Stock Units (RSUs) covering 50,000 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On August 12, 2024, the achievement of milestones for the vesting of RSUs covering 10,000 shares of Common Stock was certified. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 12, 2024 Filed Aug 15, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 220 | $115.70 | $25,454.00 |
DisclosureSEC source: 0001415889-24-021327 · form4-08142024_090803.xml · nonDerivative · entry 4 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 299,441 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. Read SEC document |
| August 12, 2024 Filed Aug 15, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 480 | $115.07 | $55,234.42 |
DisclosureSEC source: 0001415889-24-021327 · form4-08142024_090803.xml · nonDerivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 299,661 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.63 to $115.35 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 12, 2024 Filed Aug 15, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 781 | $114.11 | $89,118.66 |
DisclosureSEC source: 0001415889-24-021327 · form4-08142024_090803.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,141 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.58 to $114.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 12, 2024 Filed Aug 15, 2024 01:05 UTC |
Sheena JonathanDirector · CO-FOUNDER
|
SaleCommon Stock | 1,219 | $112.80 | $137,506.61 |
DisclosureSEC source: 0001415889-24-021327 · form4-08142024_090803.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,922 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.29 to $113.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2024 Filed Aug 10, 2024 01:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
Exercise / conversionStock Option (right to buy) · Derivative | 190,000 | $0.00 Strike: $5.40 | $0.00 |
DisclosureSEC source: 0001415889-24-021064 · form4-08092024_090801.xml · derivative · entry 4 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,496 Underlying: Common Stock · 190,000 shares Expires 2024-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| August 08, 2024 Filed Aug 10, 2024 01:40 UTC |
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
|
Exercise / conversionCommon Stock | 190,000 | $5.40 | $1,025,107.00 |
DisclosureSEC source: 0001415889-24-021064 · form4-08092024_090801.xml · nonDerivative · entry 1 Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,480,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 01:05 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 100 | $0.00 Strike: $5.40 | $0.00 |
DisclosureSEC source: 0001415889-24-020484 · form4-07312024_090707.xml · derivative · entry 3 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100 shares Expires 2024-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shares are fully exercisable. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 01:05 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
Exercise / conversionCommon Stock | 100 | $5.40 | $539.53 |
DisclosureSEC source: 0001415889-24-020484 · form4-07312024_090707.xml · nonDerivative · entry 2 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 01:05 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,866 | $99.65 | $185,946.90 |
DisclosureSEC source: 0001415889-24-020482 · form4-07312024_090701.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,955 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:05 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 929 | $102.77 | $95,469.34 |
DisclosureSEC source: 0001415889-24-020484 · form4-07312024_090707.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,462 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:05 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 1,196 | $102.77 | $122,907.78 |
DisclosureSEC source: 0001415889-24-020485 · form4-07312024_090710.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,441 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:05 UTC |
Chapman Steven LeonardDirector · CEO AND PRESIDENT
|
SaleCommon Stock | 4,084 | $102.77 | $419,695.12 |
DisclosureSEC source: 0001415889-24-020483 · form4-07312024_090705.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 206,293 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:05 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,238 | $102.77 | $127,223.94 |
DisclosureSEC source: 0001415889-24-020482 · form4-07312024_090701.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,821 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:05 UTC |
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
|
SaleCommon Stock | 1,057 | $102.77 | $108,623.34 |
DisclosureSEC source: 0001415889-24-020486 · form4-07312024_090712.xml · nonDerivative · entry 1 RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 206,400 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. Read SEC document |
| July 26, 2024 Filed Jul 27, 2024 01:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 751 | $102.18 | $76,737.18 |
DisclosureSEC source: 0001415889-24-020231 · form4-07262024_090701.xml · nonDerivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,059 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 21:05 UTC |
HEALY JAMESDirector
|
GrantCommon Stock | 177 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-020384 · form4-07302024_090708.xml · nonDerivative · entry 1 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,851 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $19,375 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 26, 2024 Filed Jul 31, 2024 01:05 UTC |
ROSENMAN HERMDirector
|
GrantCommon Stock | 206 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-020385 · form4-07302024_090710.xml · nonDerivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,587 F1 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $22,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 26, 2024 Filed Jul 31, 2024 01:05 UTC |
BOTHA ROELOFDirector
|
GrantCommon Stock | 234 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-020383 · form4-07302024_090705.xml · nonDerivative · entry 1 BOTHA ROELOF · CIK 0001222287 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,564 F1 · shares: Represents the issuance of RSUs to the Reporting Person in lieu of quarterly retainer fees of $25,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 26, 2024 Filed Jul 31, 2024 01:05 UTC |
Baynes Roy D.Director
|
GrantCommon Stock | 143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-020382 · form4-07302024_090702.xml · nonDerivative · entry 1 Baynes Roy D. · CIK 0001680739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,683 F1 · shares: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $15,625 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| July 25, 2024 Filed Jul 27, 2024 01:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 690 | $105.29 | $72,650.10 |
DisclosureSEC source: 0001415889-24-020231 · form4-07262024_090701.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,810 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| July 24, 2024 Filed Jul 27, 2024 01:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 918 | $105.53 | $96,876.54 |
DisclosureSEC source: 0001415889-24-020231 · form4-07262024_090701.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,500 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023. Read SEC document |
| July 23, 2024 Filed Jul 24, 2024 01:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 499 | $107.40 | $53,591.55 |
DisclosureSEC source: 0001415889-24-020012 · form4-07232024_090702.xml · nonDerivative · entry 5 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,418 F4 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on October 22, 2021. Read SEC document |
| July 22, 2024 Filed Jul 24, 2024 01:05 UTC |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
|
SaleCommon Stock | 549 | $105.16 | $57,732.40 |
DisclosureSEC source: 0001415889-24-020009 · form4-07232024_090709.xml · nonDerivative · entry 1 Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,391 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.73 to $105.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2024 Filed Jul 24, 2024 01:05 UTC |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
|
SaleCommon Stock | 549 | $105.16 | $57,732.68 |
DisclosureSEC source: 0001415889-24-020010 · form4-07232024_090711.xml · nonDerivative · entry 1 Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,637 F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.9850 to $105.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2024 Filed Jul 24, 2024 01:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020012 · form4-07232024_090702.xml · derivative · entry 8 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. F7 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| July 22, 2024 Filed Jul 24, 2024 01:40 UTC |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,059 | $105.16 | $111,364.02 |
DisclosureSEC source: 0001415889-24-020012 · form4-07232024_090702.xml · nonDerivative · entry 4 Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,917 F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022, respectively.. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.90 to $105.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.